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Abstract: Clinical or care pathways are developed by a multidisciplinary team of healthcare
practitioners, based on clinical evidence, and standardized processes. The evaluation of their
framework/content quality is unclear. The aim of this study was to describe which tools and domains
are able to critically evaluate the quality of clinical/care pathways. An overview of systematic reviews
was conducted, according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses,
using Medline, Embase, Science Citation Index, PsychInfo, CINAHL, and Cochrane Library, from 2015
to 2020, and with snowballing methods. The quality of the reviews was assessed with Assessment the
Methodology of Systematic Review (AMSTAR-2) and categorized with The Leuven Clinical Pathway
Compass for the definition of the five domains: processes, service, clinical, team, and financial.
We found nine reviews. Three achieved a high level of quality with AMSTAR-2. The areas classified
according to The Leuven Clinical Pathway Compass were: 9.7% team multidisciplinary involvement,
13.2% clinical (morbidity/mortality), 44.3% process (continuity-clinical integration, transitional),
5.6% financial (length of stay), and 27.0% service (patient-/family-centered care). Overall, none of
the 300 instruments retrieved could be considered a gold standard mainly because they did not
cover all the critical pathway domains outlined by Leuven and Health Technology Assessment.
This overview shows important insights for the definition of a multiprinciple framework of core
domains for assessing the quality of pathways. The core domains should consider general critical
aspects common to all pathways, but it is necessary to define specific domains for specific diseases,
fast pathways, and adapting the tool to the cultural and organizational characteristics of the health
system of each country.
Keywords: clinical pathways; clinical decision support system; quality assessment; healthcare;
clinical practice guidelines
1. Introduction
The European Pathway Association defines clinical/care pathways (CPs) as a methodology for
the mutual decision-making and organization of care processes for a specific cohort of patients
during a defined period [1]. Clinical pathways and integrated care models are increasingly used in
different European and worldwide healthcare settings, such as acute hospitals, rehabilitation centers,
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and primary care facilities [2–5]. Clinical pathways, also defined as integrated care pathways (ICP) [6],
are being used in different health care systems, primarily to improve the efficiency of hospital care and
the quality of care by reducing variations in the care processes and outcomes [7]. A CP is not defined
as a simple tool, but it is a complex intervention that is more than just a piece of paper or document,
consisting of multiple components working interactively [8,9]. The core characteristics of pathways
include many aspects: an explicit statement of goals, a multidisciplinary team of clinicians and managers,
facilitation of communication and coordination of roles, the need to be built on evidence-based best
practice, and patient/relative involvement and expectations. CP involves operational research and
methodologies, with the use of documentation, dataset, and transparent and standardized quality
assessment [10,11]; collaboration with the general practitioner and follow-up; and its impact on the
organization of clinical processes and outcomes [12,13]. Nevertheless, the effectiveness of CPs cannot
be generalized because of the insufficient number of controlled studies and because of confounding
factors and sources of contamination affecting the validity of the outcomes [5]. CPs do not always
guarantee that a care process will be perfectly organized, and a lack of consensus regarding research
outcomes is not surprising given the lack of agreement regarding structure, indicators, or domains that
define a CP [14]. One of the important traps in path development is the lack of evidence-based key
interventions and outcome indicators [15], and measuring integrated care is difficult due to the lack of
suitable tools to measure the different aspects of integration, e.g., transition from hospital to primary
care [16]. There is a meaningful interest in CPs among health care practitioners, but they are among
the least used clinical decision support instruments [17]. The biggest problem of innovation in care
practices is represented by the translation of theoretical “good practices” into operators’ daily practices;
in other words, the transition from “theoretical” efficacy to “practical” effectiveness in the real world,
outside the experimental context. However, it is controversial whether the implementation of CPs is
an economic process [18] or not [19], and CP appraisal tools describe the structure of the path and the
organization of the care methodology, but they infrequently evaluate the content of the CP, quality,
and outcomes. Another important domain includes the economic aspects, as rationalization and
optimal resource use, with particular concern for the health professionals, is one of the main strategic
goals for which CPs are designed and implemented. However, as the well-known maxim states, if you
cannot measure it, you cannot manage it [20]. When CPs are used, the rigorous evaluation of the
core framework and its implementation is a bare necessity, which includes the ability to be repeated
even when the process is over, in particular if it is necessary to assess the health outcomes. Therefore,
attention should be paid to the definition of the results to be achieved through the identification of
specific indicators so that the results are truly measurable and suitable for the pursuit of the objectives
set. The monitoring of quality, structure, process, outcome [21], and safety indicators makes it possible
to identify critical areas for improvement. Overall, an accurate and robust framework for the evaluation
of the CPs can be compliant with the health technology assessment (HTA) approach, as it is based on
multidisciplinarity and it considers a multi-domain evaluation. Of course, a set of specific criteria and
indicators is requested in order to evaluate the clinical pathways along the traditional HTA domains:
effectiveness, safety, organizational, economic, ethical, legal, and social aspects [10]. Since several tools
have been adopted to assess the quality of CPs, we decided to conduct an overview of systematic
reviews to combine, appraise, and summarize the results of related systematic reviews.
2. Methods
2.1. Research Question
Which are the essential tools and domains used to assess the quality of CPs in terms of structure,
process, and outcome?
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2.2. Search Strategy
An overview of a systematic review (SR) of the literature was conducted, in agreement with the
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) method (Figure 1).
The records were identified using an advanced search strategy on different electronic databases,
such as Medline, Embase, Science Citation Index, PsychInfo, CINAHL, and Cochrane Library,
through keywords, terms, and medical subject headings (Mesh) combined with each other through
the Boolean operators “AND” and “OR”(Figure 2).
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2.3. Definition of Measurement Instruments
We defined any measurement devices or measurement tools, such as questionnaires, checklists,
or observation forms, that can be filled out by researchers, clinicians, administrators, or patient
representatives to assess the quality of structures, processes, or outcomes associated with domain(s) or
criteria/indicator(s), such as patient engagement.
2.4. Eligibility Criteria
Reviews that observed the main objective of describing the CP quality assessment tools or
indicators or domains were included. Systematic reviews were evaluated, having to cover: (1) tools
for evaluating CPs; and (2) the attributes and/or criteria and/or domains that measure the results
and quality of a CP, and their ability to evaluate the quality of a CP critically. It was decided not to
restrict the search field, in order to collect as much information as possible. Restrictions related to the
language (English/Italian), the type of study (systematic reviews, meta-analyses), and publication date
in the last 5 years (from the beginning of 2015 to July 2020) were used. Snowballing was undertaken,
starting from the included reviews and from the references of each article. This method allowed us to
find more specific literature about a subject rapidly and relatively effortlessly.
2.5. Data Extraction
A total of 3464 records from these systematic reviews were identified (Figure 1). Duplicates were
eliminated, using a reference manager. The publications were initially subjected to a screening process
conducted by two independent researchers, aimed at assessing their potential compliance with the
eligibility criteria. The titles were evaluated first and then the abstracts. In the event of a discrepancy,
the results were discussed until an acceptable degree of concordance was reached. At the end of
the screening of the abstracts, the full texts of the relevant publications were found and analyzed,
and included if appropriate. Furthermore, each indicator was classified using the domains/areas
according to The Leuven Clinical Pathway Compass (TLCPC-2003) [22]. The TLCPC is constituted by
five areas to subdivide criteria: clinical (e.g., mortality rate), financial (e.g., length of stay), process (e.g.,
evidence-based practice and guidelines), service (e.g., patient centered care), and team indicators
(e.g., multidisciplinary involvement). The TLCPC is a conceptual framework developed to assess
the effect of CPs and to follow-up a patient population. Indicators were then classified according
to the Donabedian model (structure, process, and outcome) [23] by two independent researchers,
until complete agreement was established.
2.6. Quality Appraisal of Reviews
For quality appraisal of each review, the Assessment the Methodology of Systematic Review
(AMSTAR-2) methodological quality of systematic reviews measure tool was used [24]. This instrument
is composed by 16 items, 7 of which are critical, and including protocol, assessment of risk of bias,
justification of including/excluding studies, appropriate meta-analytic methods, and consideration
of impact of publication bias. Four options can be used to answer each item questions: “yes”,
“partial yes”, “no”, or “no meta-analysis conducted”. Moreover, based on critical items, the quality of
systematic reviews can be classified into different levels: “High”: zero or one non-critical weakness.
The systematic review provides an accurate and comprehensive summary of the results of the available
studies that score and address the question of interest; “moderate”: more than one non-critical
weakness. The systematic review has more than one weakness, but no critical flaws. It may provide
an accurate summary of the results of the available studies that were included in the review; “low”:
One critical flaw with or without non-critical weaknesses. The review has a critical flaw and may not
provide an accurate and comprehensive summary of the available studies that address the question
of interest; and “critically low”: more than one critical flaw with or without non-critical weaknesses.
The review has more than one critical flaw and should not be relied on to provide an accurate and
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comprehensive summary of the available study. Multiple non-critical weaknesses may diminish
confidence in the review, and it may be appropriate to move the overall appraisal down from moderate
to low confidence.
We recorded the protocol for this review in the PROSPERO, which was approved, and it is publicly
available under the registration number CRD42020210486.
2.7. Statistical Analysis
Data analysis included descriptive measures (e.g., counts and frequencies) of the domains and
indicators used to evaluate the clinical pathway/integrated care.
3. Results
From the 3464 articles identified, 1544 duplicates were eliminated and, out of the remaining 1920,
4 relevant reviews were obtained, while 5 reviews were obtained through snowballing (Figure 1).
Of these, six reviews relate to integrated care (IC), three reviews relate to clinical pathways (CPs),
and one study was explicitly addressed to the pediatric population (Table 1).
Table 1. Reviewsincluded.
n. Authors (Year) Title Focus
1 Vanhaecht et al., (2006) [25] Clinical pathway audit tools: a systematic review Clinical Pathways
2 Lemmens et al., (2008) [26]
Systematic review: indicators to evaluate
effectiveness of clinical pathways for
gastrointestinal surgery
Clinical Pathways
3 van Zelm et al., (2018) [27]
Development of a model care pathway for adults
undergoing colorectal cancer surgery:
evidence-based key interventions and indicators
Clinical Pathways
4 Strandberg-Larsen et al., (2009) [28]
Measurement of integrated healthcare delivery:
a systematic review of methods and future
research directions
Integrated Care
5 Lyngsø et al., (2014) [29] Instruments to assess integrated care:a systematic review Integrated Care
6 Uijen et al., (2012) [30] Measurement properties of questionnairesmeasuring continuity of care: a systematic review Integrated Health Care
7 Bautista et al., (2016) [31] Instruments measuring integrated care:a systematic review of measurement properties Integrated Care
8 Suter et al., (2017) [32] Indicators and measurement tools for healthsystems integration: a knowledge synthesis Integrated Care
9 Valentijn et al., (2019) [33]
Validation of the Rainbow Model of Integrated
Care Measurement Tools (RMIC-MTs) in renal
care for patient and care providers
Integrated Care
3.1. Terminology and Definitions of CP
According to the results of this review, conducting studies on methods for measurement of PC/ICP
is a difficult charge, because the conceptual diversity used within the fields and definitions of both is
vast. While studies aimed at CPs are able to explicitly describe the constituent domains and indicators,
studies relating to IC focus on indicators of continuity and integration of care and care processes
(Table 2).
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Table 2. Indicators used to evaluate the clinical pathway/integrated care in each domain.
The Leuven Clinical Pathway Compass
(2003) [22]
1. Vanhaecht et al.,
(2006) [25]
2. Lemmens et al.,
(2008) [26]
3. van Zelm et al.,
(2016) [27]
4. Strandberg-Larsen
et al., (2009) [28]
5. Uijen et al.,
(2012) [30]
6. Bautista et al.,
(2016) [31]
7. Suter et al.,
(2017) [32] Total
DOMAINS and Indicators n n n n n n n n (%)
(1) Team 0
Influence on team satisfaction 1 1
Multidisciplinary involvement/team
effectiveness 7 10 12 29
Physician integration within care
teams/professional Integration/nursing
care integration
5 11 6 22
Supporting services (i.e., education and
social services) 14 6 20
Total Team 72 (9.8)
(2) Clinical
Complication rate 14 14
Compliance to protocol 1 1
Discharge destination 15 15
Mortality 10 6 16
Number of admissions or length of stay
on HDU/ICU * 4 4
Number of complications/post-operative
morbidity 16 16
Number of re-admissions 3 3
Number of re-operations 2 2
Pain scores/post-operative pain 2 3 5
Post-operative treatment with fluids 2 2
Readmission rate (<30 days) 0
Removal of bladder catheter 2 3 5
Reoperation/intervention 2 2
Time taken to mobilize 11 11
Use of intravenous catheter 1 1
Stress Index 1 1
Total Clinical 98 (13.2)
(3) Process 0
Accountability 4 4
Appropriate use of antibiotics/others 1 1
Completeness and quality of
documentation/data tracked and shared
with stakeholders/informatic integration
3 1 3 1 8
Clinical outcomes being measured 2 2
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Table 2. Cont.
The Leuven Clinical Pathway Compass
(2003) [22]
1. Vanhaecht et al.,
(2006) [25]
2. Lemmens et al.,
(2008) [26]
3. van Zelm et al.,
(2016) [27]
4. Strandberg-Larsen
et al., (2009) [28]
5. Uijen et al.,
(2012) [30]
6. Bautista et al.,
(2016) [31]
7. Suter et al.,
(2017) [32] Total
Care continuity/clinical integration 8 17 172 197
EBM/guideline 5 5
Implementation of pathway 3 3
Maintenance of pathway 5 5
Number of clinical examinations
(labs, radiology) 3 3
Organizational goals and objectives
aligned across sectors 1 1
Outcome management 7 7
Performance measurement domains and
tools in place 2 2
Primary care network structures 8 8 16
Safety (risk management) 7 7
Transitional (transferring care from one
area to another) 17 17
Use of shared clinical pathways across the
continuum of healthcare (e.g., diabetes,
asthma care)
Organizational integration or coordination
and specialty/or combination
4 40 7 51
Total Process 329 (44.4)
(4) Financial
Attainment of goals and objectives are
supported by funding and human
resource allocation
1 1
Influence on length of stay 20 15 35
Influence on length of stay HDU/ICU 1 1
Influence on medical costs 5 5
Total Financial 42 (5.3)
(5) Service
Influence on patient satisfaction 6 1 7
Individualization of care pathways for
patients with co-morbidities 7 7
Patient centered care/family involvement
in care planning 3 148 34 185
Quality of life (SF-36) 1 1 2
Total Service 201 (27.3)
* HDU: High Dependency Unit; ICU: Intensive Care Unit.
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3.2. Synthesis of Reviews Included
The oldest review (Vanhaecht et al., 2006) [25] describes 15 tools applied specifically to CP, of which
7 tools were published or developed in or after 1998, and describes only 7 tools in depth. The variability
of characteristics confirms a scarcity of consensus on the concept and definition of CPs. Only one tool,
the Integrated Care Pathway appraisal tool (ICPAT) of Whittle et al., (2004) [13], was validated. The two
systematic reviews on CPs for gastrointestinal surgery (Lemmens et al., 2008) [26] and colorectal cancer
surgery (van Zelm et al., 2018) [27] do not describe tools but indicators. The criteria that were used to
evaluate clinical pathways in the literature were scored for five domains of TLCPC [22]. The most
common one is “financial”, which assesses the ability of CP to reduce the length of stay truly adverse
effects on clinical outcome. The next most common is “clinical”, as complications and re-admission
rates are commonly measured. Many clinical criteria are specific and applicable in different clinical
conditions or related to surgery (admission to intensive care unit (ICU), rates of mortality). However,
the authors underline that major attention is needed to indicators of patient safety [27], using Enhanced
Recovery After Surgery (ERAS) as a fast multimodal pathway, suggested that the different components
are applicable.
The review by Strandberg-Larsen et al., (2009) [28] identified 24 papers, published from 1979 to
2007. The authors concluded that the methods surely reflected the conceptual diversity used within
the area. There was no consensus on which information sources best captured integrated healthcare
delivery. The degree of internal validity was described in 9 of 19 articles published and none had been
thoroughly validated across different settings.
The review by Lyngsø et al., (2014) [29] found 23 measurement tools that aimed to achieve the
pivotal role of assessing the impact of integrated care models focusing on the degree of integration
based on core organizational elements. All studies include defined structural and process aspects
and six included cultural aspects; additionally, they found different components for constructing
health–system integration independent of the healthcare system or population care: patient focus,
information technology, leadership and organizational culture, commitments and incentives to
deliver integrated care, clinicals (protocols and clinical guidelines), quality improvement/performance
measurement, and financial incentives.
The review of Uijen et al., (2012) [30] included 21 questionnaires measuring continuity of care.
Seventeen instruments assessed continuity of care from the viewpoint of the patient, and four
from the position of the care practitioner and program manager. From the tools measuring these
aspects, three were created for mental illness, cancer, for complex and chronic care needs, heart failure,
and others. Other (10) tools assessed aspects of staff, health practitioners, and cross-boundary continuity.
Most questionnaires were originally developed in English, eight of which were exclusively appropriated
for the primary care setting and eight for the secondary care setting; five were developed for both
settings. The methodological quality of the tools concerning these psychometric characteristics in
terms of reliability was generally poor, and validity (cultural and criterion) was not evaluated in each
of the studies.
The systematic review by Bautista et al., (2016) [31] describes 209 instruments involving work
from Europe and the USA/Canada, Africa, and Asia-Pacific. They are available to assess integrated
care, with different psychometric characteristics, in terms of reliability, validity, and responsiveness,
which were validated in the primary care population. In addition, many tools implicated
subjects affected by non-chronic conditions, multiple chronic conditions, tumors, and mental
disorders. The majority of the instruments measured different domains, such as care integration
and patient-centered care. They as well codified, and the tools show agreement with the different
domains of the six dimensions of the Rainbow Model of Integrated Care. The results emphasize the
need for research of more high-quality studies that may measure the instrument’s features and quality.
This systematic review of the measurement properties of instruments does not directly answer how
services can be integrated or how patients want care to be delivered. It also does not provide evidence
of the effectiveness of integrated care (outcomes).
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The SR by Suter et al., (2017) [32] obtained 16 indicators/domains (Table 2) included in instruments
that measure health system integration. In total, 94 of the tools cover observational tools, questionnaires,
and other types of instruments (checklists, and indicators). Ninety-two were based on self-report,
56 completed by providers, 42 by inpatients, 10 by administrators, and 6 by either or all. Many tools
were created and validated with specific patients (e.g., pediatric, others) but could conceivably be
borrowed for the general population. Seventeen instruments measured continuity of transitional care
covering the care continuum. Some domains aimed to catch the quality and transition planning as
experienced by the life experience of the patient between acute and primary care, and other community
care services and settings. Some instruments assessed the structure, process, and outcome areas
mostly from the patient or family point of view (i.e., administrative processes, customer satisfaction,
communication, level of empowerment and empathy). This review highlights that care pathways
should develop consistency and continuity of care across staff members. Moreover, it is essential to
assess performance management, how systems share information across sectors, and whether electronic
clinical records are shared across different settings. Other assessments are on organizational culture
and leadership, physician integration within care teams and across sectors, and financial management,
with the aim of capturing whether there is connection among organizational aims and how resources
are being used. Resource allocation best practice questions cover priority-setting methods, such as
grants, funding, service monitoring, and outcome evaluation.
The article of Valentijn et al., (2019) [33] describes the development of the Rainbow Model
of Integrated Care (RMIC-MT), both patient and provider versions, which were based on the
patient-reported outcome measures. The RMIC-MTs are helpful tools for evaluating the care
coordination process on integrated renal care. Each tool may be administered to care practitioners and
patients, respectively. The RMIC-MTs identify four core domains (person-centeredness, and service,
professional, and organizational coordination), four auxiliary (community-centeredness, technical and
cultural competence, system context), and integrated care domains. The RMIC-MTs may be used as a
pre/post intervention to measure the impact of an integrated care program, as an ongoing performance
assessment tool to focus on core points of integrated service delivery across staff and organizations.
3.3. Prevalent Domains and Categorization of Indicators with Donabedian’s Model
Table 2 describes the essential characteristics of domains and/or those indicators that are evaluated
by the instruments summarized. According to the Donabedian classification, 20.2% (n = 15) were
structural indicators, 50.0% (n = 37) process indicators, and 29.7% (n = 22) outcome indicators.
3.4. Instruments/Tools
This review revealed a number of useful tools for evaluating the quality of CPs or ICs in well
over 300 cases. It is not possible to aggregate the results and describe them individually, due to their
heterogeneity with respect to the contents, domains, and indicators they use. The results relating to
the areas and domains using The Leuven Clinical Pathway Compass are summarized in Figure 3 and
Table 2. The reviews of Valentijn et al., (2019) [33] and Lyngsø et al., (2014) [29] were excluded from
these results because it is not possible to calculate the frequency of each domain of each instrument.
Researchers should refer to the original documents for greater clarity.
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3.5. Quality Appraisal of Reviews
The results relating to critical quality appraisal using AMSTAR-2 are tabulated in Table 3.
Only three reviews are of high quality according to AMSTAR-2. The others are moderate and
low quality.
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Table 3. Qualityappraisal.
n. Authors
Items of AMSTAR 2 Overall Rating
Quality1 2 * 3 4 * 5 6 7 8 9 * 10 11 * 12 13 * 14 ** 15 * 16
1 Vanhaecht et al., (2006) [25] NA PY Y PY Y Y Y Y NA N NA NA NA Y Y N Low
2 Lemmens et al., (2008) [26] NA PY Y PY Y Y Y Y NA Y NA NA NA Y Y PY Moderate
3 van Zelm et al., (2018) [27] NA PY Y Y Y Y Y Y NA Y NA NA NA Y Y N High
4 Strandberg-Larsen et al., (2009) [28] NA PY Y Y Y Y Y Y NA Y NA NA NA Y N N Low
5 Lyngsø et al., (2014) [29] NA PY Y PY N N PY PY NA N NA NA NA Y Y N Critically Low
6 Uijen et al., (2012) [30] NA PY Y PY Y Y Y Y NA Y NA NA NA Y Y Y Moderate
7 Bautista et al., (2016) [31] NA PY Y Y Y Y Y Y NA Y NA NA NA Y Y Y High
8 Suter et al., (2017) [32] NA PY Y PY Y Y Y Y NA Y NA NA NA Y Y Y Moderate
9 Valentijn et al., (2019) [33] NA PY Y Y Y Y PY Y NA Y NA NA NA Y Y Y High
Note: * Critical items ** Heterogeneity related by comparing the results of each of the studies included. NA: not applicable. PY: Partial Yes. Y: Yes. N: Not.
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4. Discussion
The purpose of this overview of systematic reviews was to describe the domains, contents,
and criteria/indicators, through a tool applicable in the evaluation of the quality of a clinical pathway
in order to identify a set of indicators that could be integrated in an evaluation framework,
consistently with the HTA approach. Standardizing care through the use of CP is an important
method to diminish the heterogeneity of the clinical process, reduce malpractice risk, guarantee high
standard of care and high quality, and reduce costs [34]. According to the results of this review,
definitions of CP and IC seem to not always be the same thing, since the conceptual diversity used
within the field and definition of both is huge, although care or critical pathways are described
as integrated care pathways [6]. The confusing and interchangeable terminology and frequently
ambiguous use of terms is a challenge for the systematic approach needed when conducting SR. In fact,
in the study of de Luc et al., (2001) [35], 17 different terms were used for clinical pathways, as described
in another study [36]. This variation in the terms used, so referring to a complex intervention
without standardizing its elements, only adds confusion towards the achievement of a standard
definition [37]. The often-discussed conceptual ambiguity of CP/IC is a crucial key in assessing the
areas of integration. Generally, “clinical pathway” is used for the pathway within a 24-h department of a
hospital. A “care pathway” is longer and includes outpatient care, after discharge from the hospital [38].
CPs are part of IC, and they are a method to fulfill an outcome, and a complex intervention to guarantee
the structure, the interdisciplinary staff process, and the follow-up of the outcomes of a specific
clinical care process. “Integrated care” is a coherent set of methods and models on the funding,
administrative, organizational, service delivery, and clinical levels designed to create connectivity,
alignment, and collaboration within and between the cure and care sectors” [32,39]. Nevertheless,
a lot of instruments were obtained from this review (over 300, data not shown) as questionnaires,
tools contained checklists and indicators, and the first audit instruments were implemented from
the 1990s [40].To date, there is no gold standard tool to assess the quality of CP/IC or a fast CP [27].
It suggests important gaps in CP/IC quality tool measurement that underscore the lack of a standard
measurement instrument and the integration of care across healthcare systems. The term gold standard
refers to an available benchmark as it is not the perfect test but solely the best available and reliable
one that has a standard with known results [41]. In our case, it is necessary to evaluate a complex
process, which takes into account the different approaches available in the literature, integrated with
each other, as described in Figure 4. This multi-principle framework proposal (Figure 4) arises from the
Donabedian model [23] integrated with that of HTA [42], The Leuven Clinical Pathway Compass [22],
and RMIC-MT [33], adapted to the health service model in each country. This proposal could guide the
construction of a multi-criteria model to define a gold standard and related indicators for assessment of
CP/ICP, in its completeness and complexity. In this direction, the Medical Research Council has made
guidance on process evaluation of complex interventions [43]. This guidance delineates and links the
key pivotal components of process assessment of complex interventions. Process evaluations cannot
provide answers to all of the uncertainties of a complex intervention [44]. It is likely that in a CP/IC,
it is necessary to identify: (1) standardizable core domains/indicators in each pathway (homogenous
patients group, diagnosis related group), (2) standardizable core domains/indicators independently of
the clinical condition, and (3) standardizable core domains/indicators in a fast multimodal pathway, e.g.,
the Enhanced Recovery After Surgery (ERAS) [27,45]. Moreover, a CP relating to the emergency area
can be recommendable, in relation to outpatient CPs, as an encouraging approach to reduce hospital
admission after emergency care [34]. De Bleser et al. [36] proposed interesting core characteristics,
aims, and outcomes for analysis of the definition of CP. It is also probable that each health system
chooses to focus on specific aspects/domains of CP/IC while dispensing with other aspects, given their
respective priorities and prevailing needs, goals, and standards in each healthcare delivery. In Italy,
for example, in the National Health System, the evaluation of CPs at regional and national level has
to be done in terms of appropriateness, clinical outcome, equity, and economic impact [46] for each
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different disease, and it seems to ignore the integration of care. Moreover, systematic measurement
methods are vital in continuously developing the knowledge base of integrated care.
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This overview of systematic reviews shows some critical issues. Firstly, only three out of nine of
these reviews, according to AMSTAR-2, are of “high” quality (Table 3), while the other reviews have
moderate and low or critically low quality. It is possible that the methodological rigor is more evident
in the reviews published from 2016 onwards, or that the methodological rigor in place was not explicitly
described. A systematic review needs to use a trans arently formulated query that uses systematic
and rigorous methods to recognize, collect and select, and critically appraise relevant research, and to
analyze information from each of the studies that are enclosed [47]. It is used to explore the best evidence
of clinical safety or effectiveness of healthcare interventions. Secondly, deficient aspects related to
stakeholder involvement are described, and low adherence criteria are described by tools related to
evidence-based models. A CP specifically states the outcomes and pivotal elements of care based
on evidence-based practice guidelines, and patient desires [36]. The development and validation of
evidence-base critical pathways for inpatient and outpatient settings is a research and clinical priority.
A transparent system of medical justice that ack owledges clinical guidelines when determining
standards of care could help reduce health practitioners’ perceived risk [34,48]. Thirdly, although most
questionnaires are culturally effective, psychometric validity and responsiveness were not evaluated
or they are of low to moderate quality i another study [30,31]. Moreover, many instruments with
desirable psychometric properties can have too many items to be practical, so they can be used
for research but are not used in routi e clinical practice. Many tools are individually capable of
measurement and some domains are specific to a particular CP. Fourthly, the management of follow-up
is unclear. A trans ural pathway is even longer than others, and covers the preliminary and the
follow-u process in primary care or another care facility [49]. Finally, although it is ifficult to compare
the reviews, they share t e need to ori nt the care to ard patient-centeredness. A recent review
describes how several initiatives t at have implemented patient participation point to its positive effects
on quality of care, i creased patient satisfaction and safety, and healthcar providers appearing to
have more empathy, which i turn results in better informed and emp ered p tie ts [50]. About the
results of th classification of the i dicators according to Donabedian, it emerged that th process
and outcome i ic tors are more sensitive to th clinical conditions or settings (medical or surgical)
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than the structural indicators, which can be more easily standardized. Moreover, HTA represents an
accurate methodological framework aimed at rationalizing the allocation of a care pathway, through the
provision of information regarding the effectiveness, safety, and use of health technologies, as well as
ethical, societal, and organizational domains [42].
The present study has some methodological limitations. Firstly, we only reviewed systematically
literature published within a short 5-year time period. This limitation was partially addressed through
the use of snowballing. Secondly, we included only two languages.
5. Conclusions
This overview further confirms the need for a more standard process of selecting appropriate
tools to assess different core constructs/domains for CP and IC, whereas the boundary between the two
pathways is not always clearly defined. It is clear that involvement of patients/family is an essential
aspect, together with multidisciplinarity and interdisciplinarity. The proposal of a multi-criteria
framework could become a guide to define a gold standard and related indicators for the assessment
of CP/ICP. Nevertheless, it is imperative to develop valid measures of assessment for the content of
the path, integration across healthcare systems, and clinical and economic outcomes. Overall, it is
worthwhile to keep in mind that each CP/IC refers to specific clinical conditions or disease cohorts.
Therefore, the process indicators are specific and are closely related to the guidelines. Determining at
least two gold standards could be useful, one general and one for a specific disease, to standardize and
evaluate the ever more complex treatment processes while also considering cost-effectiveness aspects.
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